Patents by Inventor Kenneth J. Seidenman

Kenneth J. Seidenman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and platforms for drug discovery using induced pluripotent stem cells
    Patent number: 8257941
    Abstract: The present invention involves methods for identifying an agent that corrects a phenotype associated with a health condition or a predisposition for a health condition. The invention also involves methods for identifying a diagnostic cellular phenotype, determining the risk of a health condition in a subject, methods for reducing the risk of drug toxicity in a human subject, and methods for identifying a candidate gene that contributes to a human disease. The invention also discloses human induced pluripotent stem cell lines.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: September 4, 2012
    Assignee: Kyoto University
    Inventors: Kazuhiro Sakurada, Kenneth J. Seidenman
  • METHODS AND COMPOSITIONS FOR SELECTION OF STEM CELLS
    Publication number: 20110020814
    Abstract: Described herein are methods and compositions for selection of pluripotent stem cells from a population of mammalian cells (e.g., human) undergoing a process that induces some cells within the population to become pluripotent.
    Type: Application
    Filed: June 4, 2010
    Publication date: January 27, 2011
    Applicant: IPIERIAN, INC.
    Inventors: JOHN DIMOS, KENNETH J. SEIDENMAN
  • METHODS AND PLATFORMS FOR DRUG DISCOVERY
    Publication number: 20090324559
    Abstract: The present invention involves methods for identifying an agent that corrects a phenotype associated with a health condition or a predisposition for a health condition. The invention also involves methods for identifying a diagnostic cellular phenotype, determining the risk of a health condition in a subject, methods for reducing the risk of drug toxicity in a human subject, and methods for identifying a candidate gene that contributes to a human disease. The invention also discloses human induced pluripotent stem cell lines.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 31, 2009
    Applicant: iZumi Bio, Inc.
    Inventors: Kazuhiro SAKURADA, Kenneth J. Seidenman